Daniel R. Brown, M.D., Ph.D.

Location

Contact

SUMMARY

Daniel R. Brown, M.D., Ph.D., focuses his nonclinical time on hospital administration and the transformation of healthcare delivery models. Dr. Brown holds institutional and professional society leadership positions. As a leader, he strives to develop sustainable, high-quality systems that provide care to hospitalized patients.

Trained as a basic scientist, Dr. Brown uses a data-driven approach to practice redesign. His initial efforts focused on care of the critically ill patient, and he now works at a systems level at Mayo Clinic. His related efforts address resource allocation and sustainability of high-intensity practices. The results of his work have been shared in medical literature and are available in his curriculum vitae.

Focus areas

• Critical care. Critical care is a multidisciplinary practice that has historically developed in independent specialty-specific practices. More recently, critical care organizations have formed, and disciplines work across specialties. Dr. Brown is a leader in this field and leads by the example developed at Mayo Clinic.
• Emergencies and pandemics. Responding to emergencies and pandemics benefit from coordinated action in a manner larger than single health systems. Dr. Brown has worked with and published findings generated from work done at state and national levels.
• An around-the-clock practice. A 24/7 practice, such as critical care, is associated with burnout and high employee turnover. Dr. Brown is recognized as a thought leader in describing how healthcare systems are able to develop practices that are safe, meet patient needs and support healthcare professionals.

Significance to patient care

Dr. Brown studies how to better organize hospitals to provide high-quality care for people.

Professional highlights

• Member, Governing council, Society of Critical Care Medicine, 2015-2021.
• President, Society of Critical Care Anesthesiologists, 2018-2020.
• Member, Anesthesiology and Respiratory Therapy Devices Panel, Food and Drug Administration, 2007-2018.